Upstream Bio, Inc. UPB
Super Investor & Insider
Nessuna transazione insider negli ultimi 6 mesi.
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Upstream Bio Inc. operates within the biotechnology sector, focusing on the development of innovative therapeutic solutions for advanced immunological diseases. The company aims to address unmet medical needs by leveraging cutting-edge scientific research and technology advancements. Upstream Bio Inc. emphasizes the di…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees75
TickerUPB
Statistics
Market Cap$330.9M
Revenue (TTM)$2.9M
Net Income-$143.4M
Net Margin-5026.0%
EPS$-2.90
P/E-2.41
P/S102.88
P/B1.00
EV/EBITDA-0.28
ROE-41.8%
Dividend Yield—
Price$6.08
Data: Twelve Data · Revenue = mcap / P/S